UroGen Pharma Ltd
NASDAQ:URGN 4:00:00 PM EDT
| Market Cap (Intraday) | 597.56M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $12.98 |
| 50-Day MA | $9.62 |
| 200-Day MA | $10.94 |
UroGen Pharma Ltd Stock, NASDAQ:URGN
400 Alexander Park Drive, 4th floor, Princeton, New Jersey 08540
Israel
Phone: +1.646.768.9780
Number of Employees: 235
Description
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.